Status:
UNKNOWN
Adipose Tissue Pre and Post Bariatric Surgery
Lead Sponsor:
Institut de Recherches Cliniques de Montreal
Conditions:
Obesity
Eligibility:
All Genders
18+ years
Brief Summary
Published data suggest that inflammation and fibrosis of adipose tissue could be factors favoring the development of insulin resistance in obese individuals and that a decrease in the activity of the ...
Eligibility Criteria
Inclusion
- Awaiting bariatric surgery
- BMI ≥ 35 kg/m2 without cardiometabolic complications or ≥ 30 kg/m2 if presence of type 2 diabetes or hypertension
- ≥ 18 years old
- Non smoker
- Sedentary (less than 3 hours of regular physical activity per week)
Exclusion
- Type 1 diabetes
- Acute event in the last 3 months (myocardial infarction, cerebrovascular hemorrhage or transient cerebral ischemia, unstable angina, peripheral vascular disease, revascularization or angioplasty, recent hospitalization for more than 4 days)
- Infection in the last month (fever, antibiotics treatment)
- Cancer in the last 3 years
- Chronic inflammatory disease
- Pharmacologic treatment (any medication affecting glucose metabolism (except those for diabetes), hypotensive medication unless stable dose for at least 1 month, lipid-lowering medication unless stable dose for at least 1 month)
- Uncontrolled disease of pituitary or thyroid gland
- Bleeding disorders
- Alcohol or drug abuses
- Claustrophobia
Key Trial Info
Start Date :
April 25 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2022
Estimated Enrollment :
98 Patients enrolled
Trial Details
Trial ID
NCT05304325
Start Date
April 25 2012
End Date
September 30 2022
Last Update
March 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut de recherches cliniques de Montréal
Montreal, Quebec, Canada, H2W 1R7